Evidence map›Paper›PMID 40822516›Full record

ReviewJournal of orthopaedic translation2025

Forkhead box O proteins in chondrocyte aging and diseases.

Yuchen He, Weihong Zhu, Peter G Alexander, Sophie E Hines, Olivia G Bartholomew, Chunfeng Zhao, Qian Liu, Hang Lin

Abstract readReview
In one paragraph

Review in Journal of orthopaedic translation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. From scientific discovery to orthopaedic clinical innovation.Journal of orthopaedic translation · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuchen HeDepartment of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Weihong ZhuDepartment of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Peter G AlexanderDepartment of Orthopaedics, The University of Pittsburgh, PA, USA.
Sophie E HinesDepartment of Orthopaedics, The University of Pittsburgh, PA, USA.
Olivia G BartholomewDepartment of Orthopaedics, The University of Pittsburgh, PA, USA.
Chunfeng ZhaoDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.
Qian LiuDepartment of Orthopaedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Hang LinDepartment of Orthopaedics, The University of Pittsburgh, PA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As people age, the progressive loss of cartilage integrity occurs, accompanied by a decline in the capacity to repair. This results in decreased resilience and increased susceptibility of cartilage to various physiological stressors, which raises the risk of developing osteoarthritis (OA). Therefore, restoring the regenerative capacity of chondrocytes and slowing down the aging process could be promising therapeutic strategies to mitigate or even reverse age-related joint diseases. Forkhead box class O (FoxO) proteins are a family of transcription factors that play a crucial role in various cellular processes linked to aging. Their significant functions in cell cycle regulation, apoptosis, and resistance to oxidative stress highlight their importance in maintaining cellular homeostasis and promoting longevity. In this review, we introduce the structures and functions of FoxO proteins in chondrocytes, focusing on their spatiotemporal regulation of epigenetics during chondrocyte differentiation stages in different layers. The critical roles of FoxO proteins in maintaining chondrocyte homeostasis are summarized, alongside a discussion of how FoxO dysfunction contributes to aging and OA. Furthermore, therapeutic strategies targeting FoxO proteins to mitigate aging-related cartilage degradation and decelerate OA progression are explored. Finally, potential directions for future research are proposed to deepen the current understanding of FoxO proteins. The translational potential of this article: FoxO transcription factors, especially FoxO1 and FoxO3, are promising therapeutic targets for promoting longevity, stimulating cartilage regeneration, and treating aging-related diseases like OA.

Indexed as

AgingCartilage regenerationChondrocyteForkhead box class OFoxOOsteoarthritisRejuvenation

Identifiers

PMID40822516
PMCPMC12357264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.